Vimarsana
Biggest News Aggregation in the World

Page 4 - Markm Davis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Markm Davis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Markm Davis Today - Breaking & Trending Today

2021 Szent-Györgyi Prize Awarded to Pioneering Research Duo Who Have Paved the Path to Life-Saving T-Cell Receptor-Based Cancer Immunotherapies - Vimarsana News

2021 Szent-Györgyi Prize Awarded to Pioneering Research Duo Who Have Paved the Path to Life-Saving T-Cell Receptor-Based Cancer Immunotherapies

Share this article Share this article ROCKVILLE, Md., Feb. 18, 2021 /PRNewswire/ -- The National Foundation for Cancer Research (NFCR) announced today that the 2021 Szent-Györgyi Prize for Progress in Cancer Research will be awarded to Tak W. Mak, Ph.D., senior scientist at the Princess Margaret Cancer Centre and university professor at the University of Toronto, and Mark M. Davis, Ph.D., professor of microbiology and immunology at the Stanford University School of Medicine, for their breakthrough discoveries of the structure of T-cell receptor (TCR) and pioneering research in deciphering...

Vaxart Announces Additional Preclinical COVID-19 Oral Vaccine Data and Publication - Vimarsana News

Vaxart Announces Additional Preclinical COVID-19 Oral Vaccine Data and Publication

Vaxart Announces Additional Preclinical COVID-19 Oral Vaccine Data and Publication January 26, 2021 08:30 ET | Source: Vaxart, Inc. Vaxart, Inc. South San Francisco, California, UNITED STATES New pre-clinical histology data show that Vaxart’s oral vaccine protected against lung inflammation in hamster models An article published in Nature Medicine reports data from a collaboration with Stanford University researchers on in vitro activity of Vaxart’s COVID-19 vaccine Data from Vaxart’s Phase I COVID-19 trial expected to be released next week S...

Vaxart Announces Additional Preclinical COVID-19 Oral Vaccine Data and Publication - Vimarsana News

Vaxart Announces Additional Preclinical COVID-19 Oral Vaccine Data and Publication

Published: Jan 26, 2021 New pre-clinical histology data show that Vaxart’s oral vaccine protected against lung inflammation in hamster models An article published in Nature Medicine reports data from a collaboration with Stanford University researchers on in vitro activity of Vaxart’s COVID-19 vaccine Data from Vaxart’s Phase I COVID-19 trial expected to be released next week SOUTH SAN FRANCISCO, Calif., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Vaxart Inc., (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by inject...